Viatris Property, Plant, and Equipment 2010-2024 | VTRS

Viatris property, plant, and equipment from 2010 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
  • Viatris property, plant, and equipment for the quarter ending September 30, 2024 was $2.677B, a 8.53% decline year-over-year.
  • Viatris property, plant, and equipment for 2023 was $2.76B, a 8.76% decline from 2022.
  • Viatris property, plant, and equipment for 2022 was $3.025B, a 5.15% decline from 2021.
  • Viatris property, plant, and equipment for 2021 was $3.189B, a 7.84% decline from 2020.
Viatris Annual Property, Plant, and Equipment
(Millions of US $)
2023 $2,760
2022 $3,025
2021 $3,189
2020 $3,460
2019 $2,150
2018 $2,170
2017 $2,339
2016 $2,322
2015 $1,984
2014 $1,786
2013 $1,666
2012 $1,397
2011 $1,298
2010 $1,209
2009 $1,123
Viatris Quarterly Property, Plant, and Equipment
(Millions of US $)
2024-09-30 $2,677
2024-06-30 $2,663
2024-03-31 $2,708
2023-12-31 $2,760
2023-09-30 $2,927
2023-06-30 $2,983
2023-03-31 $3,008
2022-12-31 $3,025
2022-09-30 $3,039
2022-06-30 $3,084
2022-03-31 $3,150
2021-12-31 $3,189
2021-09-30 $3,114
2021-06-30 $3,171
2021-03-31 $3,247
2020-12-31 $3,460
2020-09-30 $2,058
2020-06-30 $2,038
2020-03-31 $2,067
2019-12-31 $2,150
2019-09-30 $2,124
2019-06-30 $2,146
2019-03-31 $2,151
2018-12-31 $2,170
2018-09-30 $2,120
2018-06-30 $2,186
2018-03-31 $2,275
2017-12-31 $2,339
2017-09-30 $2,310
2017-06-30 $2,366
2017-03-31 $2,338
2016-12-31 $2,322
2016-09-30 $2,284
2016-06-30 $2,058
2016-03-31 $1,999
2015-12-31 $1,984
2015-09-30 $1,885
2015-06-30 $1,899
2015-03-31 $1,872
2014-12-31 $1,786
2014-09-30 $1,738
2014-06-30 $1,756
2014-03-31 $1,705
2013-12-31 $1,666
2013-09-30 $1,459
2013-06-30 $1,431
2013-03-31 $1,422
2012-12-31 $1,397
2012-09-30 $1,336
2012-06-30 $1,299
2012-03-31 $1,316
2011-12-31 $1,298
2011-09-30 $1,239
2011-06-30 $1,261
2011-03-31 $1,217
2010-12-31 $1,209
2010-09-30 $1,151
2010-06-30 $1,092
2010-03-31 $1,111
2009-12-31 $1,123
2009-09-30 $1,085
2009-06-30 $1,078
2009-03-31 $1,042
Sector Industry Market Cap Revenue
Medical Medical Services $15.624B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Natera (NTRA) United States $16.570B 0.00
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Medpace Holdings (MEDP) United States $11.301B 31.84
Charles River Laboratories (CRL) United States $11.285B 21.81
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00